Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

Insiders Menu
Roster
Transactions
PepGen Inc.

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
06/08/2023McArthur James GPresident and CEOSaleCommon Stock2.4k$16.04$38.2k 06/08/2023
06/08/2023McArthur James GPresident and CEOExerciseStock Option (Right to Buy)2.4k$2.71$6.5k 06/08/2023
06/07/2023McArthur James GPresident and CEOExerciseStock Option (Right to Buy)8.4k$2.71$22.8k 06/06/2023
06/07/2023McArthur James GPresident and CEOSaleCommon Stock8.4k$16.23$136.6k 06/06/2023
06/06/2023McArthur James GPresident and CEOExerciseStock Option (Right to Buy)18.2k$2.71$49.2k 06/06/2023
06/06/2023McArthur James GPresident and CEOSaleCommon Stock18.2k$16.18$293.7k 06/06/2023
06/05/2023McArthur James GPresident and CEOSaleCommon Stock500$16.06$8k 06/02/2023
06/05/2023McArthur James GPresident and CEOExerciseStock Option (Right to Buy)500$2.71$1.4k 06/02/2023
06/02/2023McArthur James GPresident and CEOExerciseStock Option (Right to Buy)1.8k$2.71$4.9k 06/02/2023
06/02/2023McArthur James GPresident and CEOSaleCommon Stock1.8k$16.04$28.9k 06/02/2023
03/01/2023Donnelly NoelCFOGrantStock Option (Right to Buy)144k$15.25$2.2M 03/01/2023
03/01/2023Svenstrup NielsSVP, Chem. Mfg & ControlsGrantStock Option (Right to Buy)75k$15.25$1.1M 03/01/2023
03/01/2023McArthur James GPresident and CEOGrantStock Option (Right to Buy)275k$15.25$4.2M 03/01/2023
03/01/2023Goyal JayaEVP, Res. & Preclin. Dev.GrantStock Option (Right to Buy)75k$15.25$1.1M 03/01/2023
03/01/2023Mellion Michelle LSVP, Clinical DevelopmentGrantStock Option (Right to Buy)75k$15.25$1.1M 03/01/2023
03/01/2023Mellion Michelle LSVP, Clinical DevelopmentGrantStock Option (Right to Buy)20k$15.25$305k 03/01/2023
02/08/2023Goyal JayaEVP, Res. & Preclin. Dev.ExerciseStock Option (Right to Buy)644$10.88$7k 02/06/2023
02/08/2023Goyal JayaEVP, Res. & Preclin. Dev.SaleCommon Stock644$17.00$10.9k 02/06/2023
02/07/2023Goyal JayaEVP, Res. & Preclin. Dev.SaleCommon Stock3.7k$17.18$63.2k 02/06/2023
02/07/2023Goyal JayaEVP, Res. & Preclin. Dev.ExerciseStock Option (Right to Buy)3.7k$10.88$40k 02/06/2023
02/06/2023Goyal JayaEVP, Res. & Preclin. Dev.SaleCommon Stock1.7k$17.04$28.6k 02/06/2023
02/06/2023Goyal JayaEVP, Res. & Preclin. Dev.ExerciseStock Option (Right to Buy)1.7k$10.88$18.2k 02/06/2023
12/19/2022Svenstrup NielsSVP, Chem. Mfg & ControlsExerciseStock Option (Right to Buy)10k$2.71$27.1k 12/19/2022
10/03/2022Dable Habib JDirectorGrantStock Option (Right to Buy)22.7k$9.31$211.2k 10/03/2022
07/01/2022Mellion Michelle LSVP, Clinical DevelopmentGrantStock Option (Right to Buy)100k$10.21$1M 07/01/2022
05/10/2022Flynn James E10% OwnerConversionCommon Stock268.5k$0.00$0Through Deerfield Partners, L.P.05/10/2022
05/10/2022Flynn James E10% OwnerPurchaseCommon Stock208.3k$12.00$2.5MThrough Deerfield Partners, L.P.05/10/2022
05/10/2022Flynn James E10% OwnerConversionSeries B Preferred Stock273.3k$0.00$0Through Deerfield Partners, L.P.05/10/2022
05/10/2022Oxford Science Enterprises plc10% OwnerConversionCommon Stock1.3M$0.00$0 05/10/2022
05/10/2022Oxford Science Enterprises plc10% OwnerConversionSeries A-2 Preferred stock962.9k$0.00$0 05/10/2022
05/10/2022Oxford Science Enterprises plc10% OwnerConversionSeries B Preferred stock1.6M$0.00$0 05/10/2022
05/10/2022RA CAPITAL MANAGEMENT, L.P.10% OwnerConversionSeries A-2 Preferred Stock2.2M$0.00$0See footnotes05/10/2022
05/10/2022RA CAPITAL MANAGEMENT, L.P.10% OwnerConversionSeries A-2 Preferred Stock425.5k$0.00$0See footnotes05/10/2022
05/10/2022RA CAPITAL MANAGEMENT, L.P.10% OwnerConversionSeries A-2 Preferred Stock211.4k$0.00$0See footnotes05/10/2022
05/10/2022RA CAPITAL MANAGEMENT, L.P.10% OwnerConversionSeries B Preferred Stock1.5M$0.00$0See footnotes05/10/2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy